David J. Yvars Group Portfolio holdings
Top Buys
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$6.06M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$3.88M |
| 3 |
Eli Lilly
LLY
|
+$3.62M |
| 4 |
Amazon
AMZN
|
+$3.34M |
| 5 |
Dollar Tree
DLTR
|
+$2.98M |
Top Sells
| 1 |
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
|
+$211K |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$208K |
| 3 |
iShares Select Dividend ETF
DVY
|
+$173K |
| 4 |
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
|
+$165K |
| 5 |
AbbVie
ABBV
|
+$121K |
Sector Composition
| 1 | Healthcare | 17.06% |
| 2 | Technology | 14.68% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Financials | 4.17% |
| 5 | Consumer Staples | 3.2% |
Similar funds
David J. Yvars Group's Q3 2022 Portfolio in Review
As of Q3 2022, David J. Yvars Group held 67 positions worth $90M, up 22% from $73.5M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
David J. Yvars Group deployed $23.5M of net new capital in Q3 2022, opening 5 new positions and adding to 16 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 13,495 shares worth $3.91M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 8.5% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $208K trimmed.
- David J. Yvars Group's largest Q3 2022 buy was Vertex Pharmaceuticals: 13,495 shares worth $3.91M.
- David J. Yvars Group added most to State Street Technology Select Sector SPDR ETF in Q3 2022, an estimated $6.06M increase.
- David J. Yvars Group's biggest Q3 2022 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $208K.
- David J. Yvars Group fully exited Eaton Vance Tax-Advantaged Dividend Income Fund in Q3 2022, selling an estimated $211K.
- David J. Yvars Group's ten largest holdings make up 62% of its $90M portfolio in Q3 2022.
- David J. Yvars Group opened 5 new positions and closed 1 in Q3 2022.
- David J. Yvars Group's portfolio value rose 22% quarter-over-quarter to $90M.
Based on David J. Yvars Group's 13F filing for Q3 2022, filed 26 Oct 2022.